Qi Liu 刘琦, RAC, CSSBB
VP, Regulatory at Tanvex Biopharma USA, Inc- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
English -
-
Chinese Mandarin -
-
French -
Topline Score
Bio
Experience
-
Tanvex Biopharma USA, Inc
-
United States
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
VP, Regulatory
-
Feb 2023 - Present
-
-
VP Quality, Planning/CMC Regulatory
-
2018 - Feb 2023
-
-
Director, Drug Product development and Manufacturing
-
2017 - 2018
-
-
Director of Project Management
-
Jul 2014 - 2018
-
-
Head of Quality
-
Jan 2012 - 2017
-
-
-
Actavis plc (now Allergan)
-
Ireland
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Sr Manager, Corp. Quality and Compliance
-
Jan 2001 - Dec 2011
5+ FDA PAI including FDA foreign inspections, 3 had zero 483 observations, & all inspections received application approval recommendation. Compliance monitoring, internal audits, training, deviation, change control, CAPA, vendor audits, due diligence audits, pharmacovigilance audits, DEA inspections. 5+ FDA PAI including FDA foreign inspections, 3 had zero 483 observations, & all inspections received application approval recommendation. Compliance monitoring, internal audits, training, deviation, change control, CAPA, vendor audits, due diligence audits, pharmacovigilance audits, DEA inspections.
-
-
-
-
Sr. Technical Services Specialist
-
1996 - 2000
Member of Integration Task Force team that developed transfer strategies and completed site transfer of over 80 products/strengths in less than three years. Managed technology transfer projects and the process validation activities (MVP, SOP, Protocols/reports) for various dosage forms, i.e. solid, liquid, and semi-solid. Implemented site cleaning validation program. Conducted annual product review per FDA requirement., Managed stability program (SOPs, test methods, study protocols) on products… Show more Member of Integration Task Force team that developed transfer strategies and completed site transfer of over 80 products/strengths in less than three years. Managed technology transfer projects and the process validation activities (MVP, SOP, Protocols/reports) for various dosage forms, i.e. solid, liquid, and semi-solid. Implemented site cleaning validation program. Conducted annual product review per FDA requirement., Managed stability program (SOPs, test methods, study protocols) on products for development, NDA and validation batches. Show less Member of Integration Task Force team that developed transfer strategies and completed site transfer of over 80 products/strengths in less than three years. Managed technology transfer projects and the process validation activities (MVP, SOP, Protocols/reports) for various dosage forms, i.e. solid, liquid, and semi-solid. Implemented site cleaning validation program. Conducted annual product review per FDA requirement., Managed stability program (SOPs, test methods, study protocols) on products… Show more Member of Integration Task Force team that developed transfer strategies and completed site transfer of over 80 products/strengths in less than three years. Managed technology transfer projects and the process validation activities (MVP, SOP, Protocols/reports) for various dosage forms, i.e. solid, liquid, and semi-solid. Implemented site cleaning validation program. Conducted annual product review per FDA requirement., Managed stability program (SOPs, test methods, study protocols) on products for development, NDA and validation batches. Show less
-
-
-
-
Head of QA/QC
-
Nov 1988 - Sep 1994
-
-
Education
-
Université du Québec à Trois-Rivières
Biophysics -
East China University of Science and Technology
Bachelor of Science (B.Sc.), Chemical Engineering -
UC Irvine
Project Management, Six Sigma Black Belt